Related Experiment Video
Updated: Jun 4, 2026
23:53
Ole Isacson: Development of New Therapies for Parkinson's Disease
Published on: April 29, 2007
[Therapeutic advances in neurology].
F Siclari1, R A du Pasquier, M Schluep
1Service de neurologie, CHUV, Lausanne.
Revue Medicale Suisse
|February 12, 2011
Summary
Neurology saw significant therapeutic progress in 2010, with new oral multiple sclerosis treatments and effective Parkinson's disease symptom management. Advances in epilepsy and carotid stenosis care also emerged.
Area of Science:
- Neurology
- Clinical Practice
- Therapeutic Advances
Context:
- 2010 marked a year of significant therapeutic developments in neurology.
- Focus on advancements impacting patient care.
- Key areas include multiple sclerosis, Parkinson's disease, epilepsy, and cerebrovascular disease.
Purpose:
- To summarize key neurological therapeutic advances from 2010.
- To highlight treatments likely to alter clinical practice.
- To provide an overview of progress in multiple sclerosis, Parkinson's disease, epilepsy, and carotid stenosis.
Summary:
- New oral treatments demonstrated efficacy in multiple sclerosis (MS).
- Comparative studies evaluated endarterectomy versus stenting for carotid stenosis.
- Novel approaches addressed non-motor symptoms in Parkinson's disease (PD).
- Pharmacological studies reported new findings in epilepsy treatment.
Impact:
- Potential to reshape patient management strategies in neurology.
- Introduction of novel therapeutic options for chronic neurological conditions.
- Improved understanding and treatment of diverse neurological disorders.
Related Concept Videos
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:14Brain Imaging
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...